微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.79% | -12.68% | -73.2% | 58/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | 6.68% | 28.96% | 27.24% | 42/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | 5.25% | 17.45% | 41.89% | 60/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | 3.7% | 17.83% | 80.49% | 53/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 2.05% | 21.3% | -60.42% | 55/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | 5.18% | -27.04% | 15.88% | 57/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | 4.47% | -29.16% | 42.36% | 67/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | 3.14% | -20.51% | 85.8% | 62/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | 1.69% | -27.47% | -76.2% | 70/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | 7.1% | 15.26% | 12.52% | 47/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | 6.31% | 7.86% | 59.75% | 52/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | 3.95% | 33% | 69.53% | 53/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | 2.33% | 36.26% | -62.18% | 52/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | 6.16% | 0.16% | 5.3% | 65/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 5.85% | 6.75% | 96.97% | 57/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 2.97% | 2.06% | 73.68% | 68/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 1.71% | 21.28% | -72.2% | 67/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 6.15% | 25.25% | 12.23% | 68/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 5.48% | 20.18% | 88.32% | 74/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 2.91% | 40.58% | 106.38% | 82/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 1.41% | 13.71% | -71.28% | 83/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 4.91% | 9.35% | 7.68% | 84/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | 4.56% | 2.47% | 120.29% | 75/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 2.07% | -11.54% | 66.94% | 85/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 1.24% | -1.59% | -72.38% | 64/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 4.49% | 11.41% | 0.9% | 89/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 4.45% | 4.22% | 90.17% | 74/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 2.34% | 0% | 85.71% | 77/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 1.26% | -20.75% | -68.73% | 78/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 4.03% | -20.36% | -5.62% | 94/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 4.27% | -27.38% | 82.48% | 75/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 2.34% | -29.52% | 47.17% | 75/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 1.59% | -22.82% | -68.58% | 64/157 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 5.06% | -60.19% | -13.95% | 82/157 | 9.62% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 5.88% | -51.72% | 77.11% | 54/157 | 8.31% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 3.32% | -64.15% | 61.17% | 68/157 | 5.56% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 2.06% | 2% | -83.79% | 41/157 | 2.1% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 12.71% | -27.41% | 4.35% | 40/157 | 6.05% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 12.18% | 2% | 31.53% | 17/157 | 5.64% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 9.26% | 2% | -47.12% | 16/157 | 3.52% | ST南新 | 81.7% | 行业排名> |